An overview of vaccine development for COVID-19

Simple item page
dc.contributor.authorShahcheraghi, Seyed H.
dc.contributor.authorAyatollahi, Jamshid
dc.contributor.authorAljabali, Alaa A. A.
dc.contributor.authorShastri, Madhur D.
dc.contributor.authorShukla, Shakti D.
dc.contributor.authorChellappan, Dinesh K.
dc.contributor.authorJha, Niraj K.
dc.contributor.authorAnand, Krishnan
dc.contributor.authorKatari, Naresh K.
dc.contributor.authorMehta, Meenu
dc.contributor.authorSatija, Saurabh
dc.contributor.authorDureja, Harish
dc.contributor.authorMishra, Vijay
dc.contributor.authorAlmutary, Abdulmajeed G.
dc.contributor.authorAlnuqaydan, Abdullah M.
dc.contributor.authorCharbe, Nitin
dc.contributor.authorPrasher, Parteek
dc.contributor.authorGupta, Gaurav
dc.contributor.authorDua, Kamal
dc.contributor.authorLotfi, Marzieh
dc.contributor.authorBakshi, Hamid A.
dc.contributor.authorTambuwala, Murtaza M.
dc.date.accessioned2025-01-20T23:53:55Z
dc.date.available2025-01-20T23:53:55Z
dc.date.issued2021
dc.description.abstractThe COVID-19 pandemic continues to endanger world health and the economy. The causative SARS-CoV-2 coronavirus has a unique replication system. The end point of the COVID-19 pandemic is either herd immunity or widespread availability of an effective vaccine. Multiple candidate vaccines - peptide, virus-like particle, viral vectors (replicating and nonreplicating), nucleic acids (DNA or RNA), live attenuated virus, recombinant designed proteins and inactivated virus - are presently under various stages of expansion, and a small number of vaccine candidates have progressed into clinical phases. At the time of writing, three major pharmaceutical companies, namely Pfizer and Moderna, have their vaccines under mass production and administered to the public. This review aims to investigate the most critical vaccines developed for COVID-19 to date.
dc.fuente.origenWOS
dc.identifier.doi10.4155/tde-2020-0129
dc.identifier.eissn2041-6008
dc.identifier.issn2041-5990
dc.identifier.urihttps://doi.org/10.4155/tde-2020-0129
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/95006
dc.identifier.wosidWOS:000623606100001
dc.issue.numero3
dc.language.isoen
dc.pagina.final244
dc.pagina.inicio235
dc.revistaTherapeutic delivery
dc.rightsacceso restringido
dc.subjectCOVID-19
dc.subjectCOVID-19 vaccines
dc.subjectSARS-CoV-2
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleAn overview of vaccine development for COVID-19
dc.typeartículo
dc.volumen12
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas